June 28, 2011

An investigational Sanofi drug for diabetes works at least as well as a similar treatment already on the market, and results in less abnormally low blood sugar, according to late-stage clinical trial results presented at the American Diabetes Association’s 71st Scientific Sessions in San Diego this past weekend.

June 28, 2011

A new study indicated that two insulin products made by French drug maker Sanofi lower blood-glucose levels to a greater extent than premixed insulin, and with improvements in quality of life and less hypoglycemia.

June 28, 2011

New data from a late-stage clinical trial of a recently approved drug for Type 2 diabetes show improved blood-sugar control in adults who take it with metformin or alone.

June 27, 2011

Abbott Diabetes Care reported Friday that a shipment of blood-glucose monitoring products was reported stolen from a shipping carrier facility in Louisville, Ky., on June 19.

June 27, 2011

Use of a drug for Type 2 diabetes made by Eli Lilly and Amylin Pharmaceuticals may lower patients’ risk of heart failure, according to a new study.

June 27, 2011

Novo Nordisk unveiled data from two extension studies at the 71st annual Scientific Sessions of the American Diabetes Association in San Diego that show its diabetes drug, when combined with other medications, may help patients achieve blood-sugar control.

June 27, 2011

Prices for the top 10 most prescribed branded diabetes drugs have risen faster at Walmart and Kmart than at other retailers, according to a published report.

June 27, 2011

An insulin product made by Eli Lilly appears likely to be more cost-effective than long-acting insulin analog, according to a study presented Friday at the American Diabetes Association’s 71st Scientific Sessions in San Diego.

June 26, 2011

Nipro Diagnostics is building around its co-branded blood-glucose meter with a line of glucose-control products, including its TruePlus glucose shot.

June 24, 2011

The charitable arm of Bristol-Myers Squibb has awarded five grants totaling $1.5 million to organizations that encourage African-American women with Type 2 diabetes to better manage their disease.

June 24, 2011

Patients with inflammatory conditions may have lower rates of diabetes if they take drugs commonly used to treat arthritis, according to a new study published in the Journal of the American Medical Association.

June 24, 2011

Despite the expansion of the diabetes drug market over the past 20 years, the rate of diabetic kidney disease has become more prevalent in the United States.

June 24, 2011

It seems that intensive-dose statin therapy is linked with a higher risk of onset diabetes, compared with moderate-dose therapy, according to an analysis published in the Journal of the American Medical Association.

June 23, 2011

Novo Nordisk has teamed up with actor Chris Noth to underscore the importance of early diabetes screening and detection.

June 22, 2011

Diabetica Research Solutions has expanded distribution of its DRSI ReStore! Energy product to Publix stores that operate in-store pharmacies.

June 22, 2011

The Department of Health and Human Services’ National Diabetes Education Program has unveiled a series of videos designed to help people make lifestyle changes and cope with the demands of diabetes.

June 20, 2011

CVS/pharmacy spent the last couple of months sponsoring nearly 300 free screening and consultation events in Atlanta, Washington, D.C., and Philadelphia targeting African-American communities. 


Part of the chain’s To Your Health program, the events were an extension of the A Su Salud events targeting Hispanic customers in Los Angeles, Dallas, Houston and Miami. To Your Health started in Atlanta on April 17, moving on to Washington, D.C., on June 12 and Philadelphia on June 19.


June 20, 2011

CVS/pharmacy has introduced its latest initiative, designed to underscore the role pharmacists play in managing ongoing medications for chronic illnesses, particularly when a patient starts a new medication.

June 20, 2011

Just after the approval of their new treatment for Type 2 diabetes, Eli Lilly and Boehringer Ingelheim plan to present data in more than two dozen presentations at the American Diabetes Association Scientific Sessions starting this week.

June 20, 2011

Last month, the Food and Drug Administration approved Tradjenta (linagliptin), an oral Type 2 diabetes drug made by German drug maker Boehringer Ingelheim and Indianapolis-based Eli Lilly. The drug belongs to the class known as dipeptidyl peptidase-4 inhibitors, which also includes Merck’s Januvia (sitagliptin). With diabetes affecting some 26 million Americans and growing rapidly, Drug Store News spoke with Wa’el Hashad, BI’s VP cardiovascular and metabolic disorders marketing, about what the approval of Tradjenta means for the diabetes market.


June 17, 2011

The Food and Drug Administration on Thursday informed the public that continued use of a Type 2 diabetes treatment made by Takeda Pharmaceuticals for more than one year may be associated with an increased risk of bladder cancer.

June 17, 2011

A popular Type 2 diabetes treatment may help Type 1 diabetics achieve control of their blood-glucose levels, according to a small, observational study conducted at the University of Buffalo.

June 17, 2011

Nipro Diagnostics and NeuroMetrix have teamed up to market a point-of-care test that is designed to evaluate such systemic neuropathies as diabetic peripheral neuropathy.

June 15, 2011

Novo Nordisk will serve as the national premier sponsor for the American Diabetes Association's annual fundraising walk in 2011 and 2012, the ADA announced.